CinCor Pharma’s $193.6 Million IPO

Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal.CinCor Pharma, Inc. (“CinCor”) (Nasdaq: CINC), a clinical-stage biopharmaceutical company focused on developing its lead…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now